View Item 

Show simple item record

Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States
dc.contributor.authorStenmark, Matthew H.
dc.contributor.authorShumway, Dean
dc.contributor.authorGuo, Cui
dc.contributor.authorVainshtein, Jeffrey
dc.contributor.authorMierzwa, Michelle
dc.contributor.authorJagsi, Reshma
dc.contributor.authorGriggs, Jennifer J.
dc.contributor.authorBanerjee, Mousumi
dc.date.accessioned2017-10-05T18:18:54Z
dc.date.available2019-01-07T18:34:36Zen
dc.date.issued2017-10
dc.identifier.citationStenmark, Matthew H.; Shumway, Dean; Guo, Cui; Vainshtein, Jeffrey; Mierzwa, Michelle; Jagsi, Reshma; Griggs, Jennifer J.; Banerjee, Mousumi (2017). "Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States." The Laryngoscope 127(10): 2270-2278.
dc.identifier.issn0023-852X
dc.identifier.issn1531-4995
dc.identifier.urihttps://hdl.handle.net/2027.42/138338
dc.publisherWiley Periodicals, Inc.
dc.subject.otherOropharyngeal squamous cell carcinoma
dc.subject.otherHPV
dc.subject.otherclinical presentation
dc.subject.otherNational Cancer Database
dc.subject.otherhuman papillomavirus
dc.titleInfluence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/138338/1/lary26566_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/138338/2/lary26566.pdf
dc.identifier.doi10.1002/lary.26566
dc.identifier.sourceThe Laryngoscope
dc.identifier.citedreferenceWorsham MJ, Stephen JK, Chen KM, et al. Improved survival with HPV among African Americans with oropharyngeal cancer. Clin Cancer Res 2013; 19: 2486 – 2492.
dc.identifier.citedreferenceRischin D, Young RJ, Fisher R, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010; 28: 4142 – 4148.
dc.identifier.citedreferenceKian Ang K, Ang KK, Harris J, et al. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer. N Engl J Med 2010; 363: 24 – 35.
dc.identifier.citedreferencePosner MR, Lorch JH, Goloubeva O, et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: A subset analysis from an international phase III trial. Ann Oncol 2011; 22: 1071 – 1077.
dc.identifier.citedreferenceFakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus‐positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261 – 269.
dc.identifier.citedreferenceGillison ML, D’Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16‐positive and human papillomavirus type 16‐negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407 – 420.
dc.identifier.citedreferenceSettle K, Posner MR, Schumaker LM, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res 2009; 2: 776 – 781.
dc.identifier.citedreferenceNasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral‐induced carcinoma? Int J Cancer 2009; 125: 362 – 366.
dc.identifier.citedreferenceLassen P, Eriksen JG, Krogdahl A, et al. The influence of HPV‐associated p16‐expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial. Radiother Oncol 2011; 100: 49 – 55.
dc.identifier.citedreferenceRyerson AB, Peters ES, Coughlin SS, et al. Burden of potentially human papillomavirus‐associated cancers of the oropharynx and oral cavity in the US, 1998–2003. Cancer 2008; 113: 2901 – 2909.
dc.identifier.citedreferenceChaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus‐related and ‐unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612 – 619.
dc.identifier.citedreferenceBilimoria KY, Stewart AK, Winchester DP, et al. The National Cancer data base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2008; 15: 683 – 690.
dc.identifier.citedreferenceO’Sullivan B, Huang SH, Siu LL, et al. Deintensification candidate subgroups in human papillomavirus‐related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 2013; 31: 543 – 550.
dc.identifier.citedreferenceLin BM, Wang H, D’Souza G, et al. Long‐term prognosis and risk factors among patients with HPV‐associated oropharyngeal squamous cell carcinoma. Cancer 2013; 119: 3462 – 3471.
dc.identifier.citedreferenceVainshtein JM, Spector ME, McHugh JB, et al. Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus‐associated oropharyngeal cancer. Oral Oncol 2014; 50: 513 – 519.
dc.identifier.citedreferenceZevallos JP, Sandulache VC, Hamblin J, et al. Impact of race on oropharyngeal squamous cell carcinoma presentation and outcomes among veterans. Head Neck 2016; 38: 44 – 50.
dc.identifier.citedreferenceD’Souza G, Agrawal Y, Halpern J, et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199: 1263 – 1269.
dc.identifier.citedreferenceRoetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 1999; 91: 1409 – 1415.
dc.identifier.citedreferenceChen AY, Schrag NM, Halpern MT, et al. The impact of health insurance status on stage at diagnosis of oropharyngeal cancer. Cancer 2007; 110: 395 – 402.
dc.identifier.citedreferenceHuang SH, Perez‐Ordonez B, Weinreb I, et al. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV‐related oropharyngeal cancer. Oral Oncol 2013; 49: 79 – 85.
dc.identifier.citedreferenceNguyen‐Tan PF, Zhang Q, Ang KK, et al. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the radiation therapy oncology group 0129 trial: long‐term report of efficacy and toxicity. J Clin Oncol 2014; 32: 3858 – 3867.
dc.identifier.citedreferenceJordan RC, Lingen MW, Perez‐Ordonez B, et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol 2012; 36: 945 – 954.
dc.identifier.citedreferenceSturgis EM, Dahlstrom KR, Garden AS, et al. Proposed staging system for patients with HPV‐related oropharyngeal cancer based on nasopharyngeal cancer N categories. J Clin Oncol 2016; 34: 1848 – 1854.
dc.identifier.citedreferenceHuang SH, Xu W, Waldron J, et al. Refining American joint committee on cancer/union for international cancer control TNM stage and prognostic groups for human papillomavirus‐related oropharyngeal carcinomas. J Clin Oncol 2015; 33: 836 – 845.
dc.identifier.citedreferenceQuon H, Forastiere AA. Controversies in treatment deintensification of human papillomavirus‐associated oropharyngeal carcinomas: should we, how should we, and for whom? J Clin Oncol 2013; 31: 520 – 522.
dc.identifier.citedreferenceChaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294 – 4301.
dc.identifier.citedreferenceChaturvedi AK, Anderson WF, Lortet‐Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013; 31: 4550 – 4559.
dc.identifier.citedreferenceAuluck A, Hislop G, Bajdik C, et al. Trends in oropharyngeal and oral cavity cancer incidence of Human Papillomavirus (HPV)‐related and HPV‐unrelated sites in a multicultural population: The British Columbia experience. Cancer 2010; 116: 2635 – 2644.
dc.identifier.citedreferenceHammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006; 119: 2620 – 2623.
dc.identifier.citedreferenceBraakhuis BJM, Visser O, Leemans CR. Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adults. Oral Oncol 2009; 45: e85 – e89.
dc.identifier.citedreferenceConway DI, Stockton DL, Warnakulasuriya KAAS, et al. Incidence of oral and oropharyngeal cancer in United Kingdom (1990–1999)‐recent trends and regional variation. Oral Oncol 2006; 42: 586 – 592.
dc.identifier.citedreferenceGillison ML. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709 – 720.
dc.identifier.citedreferenceMehanna H, Beech T, Nicholson T, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer‐systematic review and meta‐analysis of trends by time and region. Head Neck 2013; 35: 747 – 755.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
lary26566_am.pdf
Size:
387.2KB
Format:
PDF
View/Open
Name:
lary26566.pdf
Size:
199.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.